MedTrace Logo

Robotic-assisted Training After Upper Arm Fracture

NCT03100201 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2020-04-24

No results posted yet for this study

Summary

In this study, patients with upper arm fracture will receive an additive robotic-assisted training using the Armeo®Spring robot for three weeks on the injured arm in addition to conventional physio- and occupational therapy. The supportive treatment and execution of specific exercises on the Armeo®Spring should lead to improved recovery of function and mobility of the upper arm compared to conservatively treated patients.

Conditions

  • Shoulder Injury

Interventions

OTHER

Intervention Armeo®Spring

The robotic-assisted training will be performed using the clinically evaluated Armeo®Spring medical device (Hocoma AG, Zurich, Switzerland). By means of a sensory orthosis, arm movements will be supported and transmitted to a computer system and visually shown on a screen.

OTHER

Control Group

The control group will receive conventional occupational- and physiotherapy over 3 weeks

Sponsors & Collaborators

  • BG Unfallklinik Murnau

    collaborator OTHER

  • Berufsgenossenschaftliche Unfallklinik Ludwigshafen

    collaborator OTHER

  • Deutsche Gesetzliche Unfallversicherung (DGUV)

    collaborator UNKNOWN

  • Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)

    lead OTHER

Principal Investigators

  • Peter Augat, Prof. · BG Unfallklinik Murnau

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-15
Primary Completion
2018-12-15
Completion
2019-12-01

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03100201 on ClinicalTrials.gov